BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guan B, Yue P, Lotan R, Sun SY. Evidence that the human death receptor 4 is regulated by activator protein 1. Oncogene. 2002;21:3121-3129. [PMID: 12082627 DOI: 10.1038/sj.onc.1205430] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Oh YT, Yue P, Sun SY. DR5 suppression induces sphingosine-1-phosphate-dependent TRAF2 polyubiquitination, leading to activation of JNK/AP-1 and promotion of cancer cell invasion. Cell Commun Signal 2017;15:18. [PMID: 28482915 DOI: 10.1186/s12964-017-0174-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
2 Maldonado ME, Bousserouel S, Gossé F, Lobstein A, Raul F. Implicación de NF-κB y p53 en la expresión de receptores de muerte-TRAIL y apoptosis por procianidinas en células metastásicas humanas SW620. biomedica 2011;30:577. [DOI: 10.7705/biomedica.v30i4.296] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
3 Arakawa S, Takahashi A, Ashikawa K, Hosono N, Aoi T, Yasuda M, Oshima Y, Yoshida S, Enaida H, Tsuchihashi T, Mori K, Honda S, Negi A, Arakawa A, Kadonosono K, Kiyohara Y, Kamatani N, Nakamura Y, Ishibashi T, Kubo M. Genome-wide association study identifies two susceptibility loci for exudative age-related macular degeneration in the Japanese population. Nat Genet 2011;43:1001-4. [PMID: 21909106 DOI: 10.1038/ng.938] [Cited by in Crossref: 96] [Cited by in F6Publishing: 83] [Article Influence: 8.7] [Reference Citation Analysis]
4 Sasaki H, Ohara N, Xu Q, Wang J, DeManno DA, Chwalisz K, Yoshida S, Maruo T. A novel selective progesterone receptor modulator asoprisnil activates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated signaling pathway in cultured human uterine leiomyoma cells in the absence of comparable effects on myometrial cells. J Clin Endocrinol Metab 2007;92:616-23. [PMID: 17105846 DOI: 10.1210/jc.2006-0898] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
5 Bhoumik A, Huang TG, Ivanov V, Gangi L, Qiao RF, Woo SL, Chen SH, Ronai Z. An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis. J Clin Invest. 2002;110:643-650. [PMID: 12208865 DOI: 10.1172/jci0216081] [Cited by in Crossref: 49] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
6 Johnston JB, Kabore AF, Strutinsky J, Hu X, Paul JT, Kropp DM, Kuschak B, Begleiter A, Gibson SB. Role of the TRAIL/APO2-L death receptors in chlorambucil- and fludarabine-induced apoptosis in chronic lymphocytic leukemia. Oncogene 2003;22:8356-69. [DOI: 10.1038/sj.onc.1207004] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 2.5] [Reference Citation Analysis]
7 Aguilera DG, Das CM, Sinnappah-Kang ND, Joyce C, Taylor PH, Wen S, Hasselblatt M, Paulus W, Fuller G, Wolff JE, Gopalakrishnan V. Reactivation of death receptor 4 (DR4) expression sensitizes medulloblastoma cell lines to TRAIL. J Neurooncol 2009;93:303-18. [PMID: 19148581 DOI: 10.1007/s11060-008-9788-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
8 Henson ES, Johnston JB, Gibson SB. The role of TRAIL death receptors in the treatment of hematological malignancies. Leukemia & Lymphoma 2009;49:27-35. [DOI: 10.1080/10428190701713655] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
9 Kurita S, Mott JL, Almada LL, Bronk SF, Werneburg NW, Sun SY, Roberts LR, Fernandez-Zapico ME, Gores GJ. GLI3-dependent repression of DR4 mediates hedgehog antagonism of TRAIL-induced apoptosis. Oncogene 2010;29:4848-58. [PMID: 20562908 DOI: 10.1038/onc.2010.235] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
10 Maksimovic-ivanic D, Stosic-grujicic S, Nicoletti F, Mijatovic S. Resistance to TRAIL and how to surmount it. Immunol Res 2012;52:157-68. [DOI: 10.1007/s12026-012-8284-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 4.0] [Reference Citation Analysis]
11 Zhang XY, Zhang XD, Borrow JM, Nguyen T, Hersey P. Translational control of tumor necrosis factor-related apoptosis-inducing ligand death receptor expression in melanoma cells. J Biol Chem 2004;279:10606-14. [PMID: 14688276 DOI: 10.1074/jbc.M308211200] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
12 Schmidt M, Hupe M, Endres N, Raghavan B, Kavuri S, Geserick P, Goebeler M, Leverkus M. The contact allergen nickel sensitizes primary human endothelial cells and keratinocytes to TRAIL-mediated apoptosis. J Cell Mol Med 2010;14:1760-76. [PMID: 19538462 DOI: 10.1111/j.1582-4934.2009.00823.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
13 Liu X, Yue P, Zhou Z, Khuri FR, Sun S. Death Receptor Regulation and Celecoxib-Induced Apoptosis in Human Lung Cancer Cells. JNCI Journal of the National Cancer Institute 2004;96:1769-80. [DOI: 10.1093/jnci/djh322] [Cited by in Crossref: 181] [Cited by in F6Publishing: 158] [Article Influence: 10.1] [Reference Citation Analysis]
14 Zhang S, Li Z, Huang W. Interleukin-4 Enhances the Sensitivity of Human Monocytes to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Through Upregulation of Death Receptor 4. J Interferon Cytokine Res 2018;38:186-94. [PMID: 29638207 DOI: 10.1089/jir.2017.0103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Ivanov VN, Hei TK. Arsenite sensitizes human melanomas to apoptosis via tumor necrosis factor alpha-mediated pathway. J Biol Chem. 2004;279:22747-22758. [PMID: 15028728 DOI: 10.1074/jbc.M314131200] [Cited by in Crossref: 47] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
16 Deng Z, Yan H, Hu J, Zhang S, Peng P, Liu Q, Guo D. Hepatitis C virus sensitizes host cells to TRAIL-induced apoptosis by up-regulating DR4 and DR5 via a MEK1-dependent pathway. PLoS One 2012;7:e37700. [PMID: 22662193 DOI: 10.1371/journal.pone.0037700] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
17 Mendoza FJ, Ishdorj G, Hu X, Gibson SB. Death receptor-4 (DR4) expression is regulated by transcription factor NF-kappaB in response to etoposide treatment. Apoptosis 2008;13:756-70. [PMID: 18421578 DOI: 10.1007/s10495-008-0210-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 3.0] [Reference Citation Analysis]
18 Chen LH, Liu XS, Wang WY, Han WN, Pan BR, Jin BQ. Localization of TRAIL/TRAILR in fetal pancreas. World J Gastroenterol 2003; 9(2): 334-337 [PMID: 12532461 DOI: 10.3748/wjg.v9.i2.334] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
19 Wu GS. TRAIL as a target in anti-cancer therapy. Cancer Lett. 2009;285:1-5. [PMID: 19299078 DOI: 10.1016/j.canlet.2009.02.029] [Cited by in Crossref: 103] [Cited by in F6Publishing: 95] [Article Influence: 7.9] [Reference Citation Analysis]
20 Ivanov VN, Zhou H, Hei TK. Sequential treatment by ionizing radiation and sodium arsenite dramatically accelerates TRAIL-mediated apoptosis of human melanoma cells. Cancer Res 2007;67:5397-407. [PMID: 17545621 DOI: 10.1158/0008-5472.CAN-07-0551] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
21 Ilmarinen P, Moilanen E, Kankaanranta H. Regulation of spontaneous eosinophil apoptosis-a neglected area of importance. J Cell Death 2014;7:1-9. [PMID: 25278781 DOI: 10.4137/JCD.S13588] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
22 Drosopoulos KG, Roberts ML, Cermak L, Sasazuki T, Shirasawa S, Andera L, Pintzas A. Transformation by oncogenic RAS sensitizes human colon cells to TRAIL-induced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway. J Biol Chem. 2005;280:22856-22867. [PMID: 15757891 DOI: 10.1074/jbc.M412483200] [Cited by in Crossref: 59] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
23 Ivanov VN, Hei TK. Sodium arsenite accelerates TRAIL-mediated apoptosis in melanoma cells through upregulation of TRAIL-R1/R2 surface levels and downregulation of cFLIP expression. Exp Cell Res 2006;312:4120-38. [PMID: 17070520 DOI: 10.1016/j.yexcr.2006.09.019] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
24 Ruiz de Almodóvar C, López-Rivas A, Redondo JM, Rodríguez A. Transcription initiation sites and promoter structure of the human TRAIL-R3 gene. FEBS Lett 2002;531:304-8. [PMID: 12417331 DOI: 10.1016/s0014-5793(02)03544-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
25 Akahane K, Inukai T, Zhang X, Hirose K, Kuroda I, Goi K, Honna H, Kagami K, Nakazawa S, Endo K, Kubota T, Yagita H, Koyama-Okazaki T, Sugita K. Resistance of T-cell acute lymphoblastic leukemia to tumor necrosis factor--related apoptosis-inducing ligand-mediated apoptosis. Exp Hematol 2010;38:885-95. [PMID: 20670671 DOI: 10.1016/j.exphem.2010.06.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
26 Guo L, Fan L, Ren J, Pang Z, Ren Y, Li J, Wen Z, Qian Y, Zhang L, Ma H, Jiang X. Combination of TRAIL and actinomycin D liposomes enhances antitumor effect in non-small cell lung cancer. Int J Nanomedicine 2012;7:1449-60. [PMID: 22619505 DOI: 10.2147/IJN.S24711] [Cited by in Crossref: 2] [Cited by in F6Publishing: 13] [Article Influence: 0.2] [Reference Citation Analysis]
27 Guseva NV, Taghiyev AF, Rokhlin OW, Cohen MB. Death receptor-induced cell death in prostate cancer. J Cell Biochem 2004;91:70-99. [PMID: 14689583 DOI: 10.1002/jcb.10707] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
28 Dhandapani L, Yue P, Ramalingam SS, Khuri FR, Sun SY. Retinoic acid enhances TRAIL-induced apoptosis in cancer cells by upregulating TRAIL receptor 1 expression. Cancer Res 2011;71:5245-54. [PMID: 21685476 DOI: 10.1158/0008-5472.CAN-10-4180] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
29 Van Geelen CM, de Vries EG, de Jong S. Lessons from TRAIL-resistance mechanisms in colorectal cancer cells: paving the road to patient-tailored therapy. Drug Resist Updat 2004;7:345-58. [PMID: 15790545 DOI: 10.1016/j.drup.2004.11.002] [Cited by in Crossref: 113] [Cited by in F6Publishing: 102] [Article Influence: 6.6] [Reference Citation Analysis]
30 Dolloff NG, Mayes PA, Hart LS, Dicker DT, Humphreys R, El-Deiry WS. Off-target lapatinib activity sensitizes colon cancer cells through TRAIL death receptor up-regulation. Sci Transl Med 2011;3:86ra50. [PMID: 21653830 DOI: 10.1126/scitranslmed.3001384] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
31 Oh YT, Yue P, Wang D, Tong JS, Chen ZG, Khuri FR, Sun SY. Suppression of death receptor 5 enhances cancer cell invasion and metastasis through activation of caspase-8/TRAF2-mediated signaling. Oncotarget 2015;6:41324-38. [PMID: 26510914 DOI: 10.18632/oncotarget.5847] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
32 Zhuang L, Lee CS, Scolyer RA, Mccarthy SW, Zhang XD, Thompson JF, Screaton G, Hersey P. Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor–related apoptosis-inducing ligand. Human Pathology 2006;37:1286-94. [DOI: 10.1016/j.humpath.2006.04.026] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
33 Zhang X, Inukai T, Hirose K, Akahane K, Kuroda I, Honna-Oshiro H, Kagami K, Goi K, Nakamura K, Kobayashi M, Endo M, Yagita H, Kurosawa H, Thomas Look A, Honda H, Inaba T, Nakazawa S, Sugita K. Oncogenic fusion E2A-HLF sensitizes t(17;19)-positive acute lymphoblastic leukemia to TRAIL-mediated apoptosis by upregulating the expression of death receptors. Leukemia 2012;26:2483-93. [PMID: 22743623 DOI: 10.1038/leu.2012.139] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
34 Polyakov VR, Moorcroft ND, Drawid A. Enrichment Analysis for Discovering Biological Associations in Phenotypic Screens. J Chem Inf Model 2014;54:377-86. [DOI: 10.1021/ci400245c] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
35 Deng L, Vallega KA, Zhang S, Shi P, Sun SY. MET inhibition downregulates DR4 expression in MET-amplified lung cancer cells with acquired resistance to EGFR inhibitors through suppressing AP-1-mediated transcription. Neoplasia 2021;23:766-74. [PMID: 34233230 DOI: 10.1016/j.neo.2021.06.006] [Reference Citation Analysis]
36 Bhoumik A, Huang TG, Ivanov V, Gangi L, Qiao RF, Woo SL, Chen SH, Ronai Z. An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis. J Clin Invest 2002;110:643-50. [PMID: 12208865 DOI: 10.1172/JCI16081] [Cited by in F6Publishing: 38] [Reference Citation Analysis]
37 Yao W, Oh YT, Deng J, Yue P, Deng L, Huang H, Zhou W, Sun SY. Expression of Death Receptor 4 Is Positively Regulated by MEK/ERK/AP-1 Signaling and Suppressed upon MEK Inhibition. J Biol Chem 2016;291:21694-702. [PMID: 27576686 DOI: 10.1074/jbc.M116.738302] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
38 Twomey JD, Kim SR, Zhao L, Bozza WP, Zhang B. Spatial dynamics of TRAIL death receptors in cancer cells. Drug Resist Updat 2015;19:13-21. [PMID: 25840763 DOI: 10.1016/j.drup.2015.02.001] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 6.4] [Reference Citation Analysis]
39 Cheng CC, Yang SM, Huang CY, Chen JC, Chang WM, Hsu SL. Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cancer Chemother Pharmacol. 2005;55:531-540. [PMID: 15739095 DOI: 10.1007/s00280-004-0919-6] [Cited by in Crossref: 89] [Cited by in F6Publishing: 84] [Article Influence: 5.2] [Reference Citation Analysis]
40 Zhang S, Chen Z, Shi P, Fan S, He Y, Wang Q, Li Y, Ramalingam SS, Owonikoko TK, Sun SY. Downregulation of death receptor 4 is tightly associated with positive response of EGFR mutant lung cancer to EGFR-targeted therapy and improved prognosis. Theranostics 2021;11:3964-80. [PMID: 33664875 DOI: 10.7150/thno.54824] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
41 Li T, Su L, Lei Y, Liu X, Zhang Y, Liu X. DDIT3 and KAT2A Proteins Regulate TNFRSF10A and TNFRSF10B Expression in Endoplasmic Reticulum Stress-mediated Apoptosis in Human Lung Cancer Cells. J Biol Chem 2015;290:11108-18. [PMID: 25770212 DOI: 10.1074/jbc.M115.645333] [Cited by in Crossref: 46] [Cited by in F6Publishing: 29] [Article Influence: 6.6] [Reference Citation Analysis]
42 Oh YT, Yue P, Zhou W, Balko JM, Black EP, Owonikoko TK, Khuri FR, Sun SY. Oncogenic Ras and B-Raf proteins positively regulate death receptor 5 expression through co-activation of ERK and JNK signaling. J Biol Chem 2012;287:257-67. [PMID: 22065586 DOI: 10.1074/jbc.M111.304006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
43 Wang M, Wang M, Cheng G, Zhang Z, Fu G, Zhang Z. Genetic variants in the death receptor 4 gene contribute to susceptibility to bladder cancer. Mutat Res 2009;661:85-92. [PMID: 19070628 DOI: 10.1016/j.mrfmmm.2008.11.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]